Latest news
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeatMarketBeat · Thu, 06 Aug 2026 06:36:34 GMTHC Wainwright Analysts Increase Earnings Estimates for MDGL - MarketBeatMarketBeat · Tue, 04 Aug 2026 12:20:04 GMTPrincipal Financial Group Inc. Sells 6,022 Shares of Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeatMarketBeat · Sat, 01 Aug 2026 10:14:08 GMTEversept Partners LP Buys Shares of 10,000 Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeatMarketBeat · Tue, 28 Jul 2026 07:00:00 GMTMadrigal Pharmaceuticals, Inc. $MDGL is Rock Springs Capital Management LP's 3rd Largest Position - MarketBeatMarketBeat · Tue, 28 Jul 2026 07:00:00 GMT